Global Transdermal Drug Patches Market Insights, Forecast to 2026
Table of Contents1 Study Coverage
1.1 Transdermal Drug Patches Product Introduction
1.2 Market Segments
1.3 Key Transdermal Drug Patches Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Transdermal Drug Patches Market Size Growth Rate by Type
1.4.2 Fentanyl Transdermal Patch
1.4.3 Nicotine Transdermal Patch
1.4.4 Buprenorphine Transdermal Patch
1.4.5 Clonidine Transdermal Patch
1.4.6 Oxybutynin Transdermal Patch
1.4.7 Others
1.5 Market by Application
1.5.1 Global Transdermal Drug Patches Market Size Growth Rate by Application
1.5.2 Used for Hypertension
1.5.3 Used for Contraception
1.5.4 Used for Analgesia
1.5.5 Used for Smoking Cessation
1.5.6 Used for Angina
1.5.7 Used for Hormone Replacement
1.6 Coronavirus Disease 2019 (Covid-19): Transdermal Drug Patches Industry Impact
1.6.1 How the Covid-19 is Affecting the Transdermal Drug Patches Industry
1.6.1.1 Transdermal Drug Patches Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Transdermal Drug Patches Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Transdermal Drug Patches Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Transdermal Drug Patches Market Size Estimates and Forecasts
2.1.1 Global Transdermal Drug Patches Revenue 2015-2026
2.1.2 Global Transdermal Drug Patches Sales 2015-2026
2.2 Transdermal Drug Patches Market Size by Region: 2020 Versus 2026
2.2.1 Global Transdermal Drug Patches Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Transdermal Drug Patches Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Transdermal Drug Patches Competitor Landscape by Players
3.1 Transdermal Drug Patches Sales by Manufacturers
3.1.1 Transdermal Drug Patches Sales by Manufacturers (2015-2020)
3.1.2 Transdermal Drug Patches Sales Market Share by Manufacturers (2015-2020)
3.2 Transdermal Drug Patches Revenue by Manufacturers
3.2.1 Transdermal Drug Patches Revenue by Manufacturers (2015-2020)
3.2.2 Transdermal Drug Patches Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Transdermal Drug Patches Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Transdermal Drug Patches Revenue in 2019
3.2.5 Global Transdermal Drug Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Transdermal Drug Patches Price by Manufacturers
3.4 Transdermal Drug Patches Manufacturing Base Distribution, Product Types
3.4.1 Transdermal Drug Patches Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Transdermal Drug Patches Product Type
3.4.3 Date of International Manufacturers Enter into Transdermal Drug Patches Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Transdermal Drug Patches Market Size by Type (2015-2020)
4.1.1 Global Transdermal Drug Patches Sales by Type (2015-2020)
4.1.2 Global Transdermal Drug Patches Revenue by Type (2015-2020)
4.1.3 Transdermal Drug Patches Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Transdermal Drug Patches Market Size Forecast by Type (2021-2026)
4.2.1 Global Transdermal Drug Patches Sales Forecast by Type (2021-2026)
4.2.2 Global Transdermal Drug Patches Revenue Forecast by Type (2021-2026)
4.2.3 Transdermal Drug Patches Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Transdermal Drug Patches Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Transdermal Drug Patches Market Size by Application (2015-2020)
5.1.1 Global Transdermal Drug Patches Sales by Application (2015-2020)
5.1.2 Global Transdermal Drug Patches Revenue by Application (2015-2020)
5.1.3 Transdermal Drug Patches Price by Application (2015-2020)
5.2 Transdermal Drug Patches Market Size Forecast by Application (2021-2026)
5.2.1 Global Transdermal Drug Patches Sales Forecast by Application (2021-2026)
5.2.2 Global Transdermal Drug Patches Revenue Forecast by Application (2021-2026)
5.2.3 Global Transdermal Drug Patches Price Forecast by Application (2021-2026)
6 North America
6.1 North America Transdermal Drug Patches by Country
6.1.1 North America Transdermal Drug Patches Sales by Country
6.1.2 North America Transdermal Drug Patches Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Transdermal Drug Patches Market Facts & Figures by Type
6.3 North America Transdermal Drug Patches Market Facts & Figures by Application
7 Europe
7.1 Europe Transdermal Drug Patches by Country
7.1.1 Europe Transdermal Drug Patches Sales by Country
7.1.2 Europe Transdermal Drug Patches Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Transdermal Drug Patches Market Facts & Figures by Type
7.3 Europe Transdermal Drug Patches Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Transdermal Drug Patches by Region
8.1.1 Asia Pacific Transdermal Drug Patches Sales by Region
8.1.2 Asia Pacific Transdermal Drug Patches Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Transdermal Drug Patches Market Facts & Figures by Type
8.3 Asia Pacific Transdermal Drug Patches Market Facts & Figures by Application
9 Latin America
9.1 Latin America Transdermal Drug Patches by Country
9.1.1 Latin America Transdermal Drug Patches Sales by Country
9.1.2 Latin America Transdermal Drug Patches Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Transdermal Drug Patches Market Facts & Figures by Type
9.3 Central & South America Transdermal Drug Patches Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Transdermal Drug Patches by Country
10.1.1 Middle East and Africa Transdermal Drug Patches Sales by Country
10.1.2 Middle East and Africa Transdermal Drug Patches Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Transdermal Drug Patches Market Facts & Figures by Type
10.3 Middle East and Africa Transdermal Drug Patches Market Facts & Figures by Application
11 Company Profiles
11.1 Noven
11.1.1 Noven Corporation Information
11.1.2 Noven Description, Business Overview and Total Revenue
11.1.3 Noven Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Noven Transdermal Drug Patches Products Offered
11.1.5 Noven Recent Development
11.2 Mylan
11.2.1 Mylan Corporation Information
11.2.2 Mylan Description, Business Overview and Total Revenue
11.2.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Mylan Transdermal Drug Patches Products Offered
11.2.5 Mylan Recent Development
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Description, Business Overview and Total Revenue
11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis Transdermal Drug Patches Products Offered
11.3.5 Novartis Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Description, Business Overview and Total Revenue
11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Johnson & Johnson Transdermal Drug Patches Products Offered
11.4.5 Johnson & Johnson Recent Development
11.5 Agile Therapeutics
11.5.1 Agile Therapeutics Corporation Information
11.5.2 Agile Therapeutics Description, Business Overview and Total Revenue
11.5.3 Agile Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Agile Therapeutics Transdermal Drug Patches Products Offered
11.5.5 Agile Therapeutics Recent Development
11.6 Teikoku Pharma USA
11.6.1 Teikoku Pharma USA Corporation Information
11.6.2 Teikoku Pharma USA Description, Business Overview and Total Revenue
11.6.3 Teikoku Pharma USA Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Teikoku Pharma USA Transdermal Drug Patches Products Offered
11.6.5 Teikoku Pharma USA Recent Development
11.7 Immune Pharmaceuticals
11.7.1 Immune Pharmaceuticals Corporation Information
11.7.2 Immune Pharmaceuticals Description, Business Overview and Total Revenue
11.7.3 Immune Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Immune Pharmaceuticals Transdermal Drug Patches Products Offered
11.7.5 Immune Pharmaceuticals Recent Development
11.8 Hercon Pharmaceuticals
11.8.1 Hercon Pharmaceuticals Corporation Information
11.8.2 Hercon Pharmaceuticals Description, Business Overview and Total Revenue
11.8.3 Hercon Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Hercon Pharmaceuticals Transdermal Drug Patches Products Offered
11.8.5 Hercon Pharmaceuticals Recent Development
11.9 Pocono
11.9.1 Pocono Corporation Information
11.9.2 Pocono Description, Business Overview and Total Revenue
11.9.3 Pocono Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Pocono Transdermal Drug Patches Products Offered
11.9.5 Pocono Recent Development
11.10 DURECT Corporation
11.10.1 DURECT Corporation Corporation Information
11.10.2 DURECT Corporation Description, Business Overview and Total Revenue
11.10.3 DURECT Corporation Sales, Revenue and Gross Margin (2015-2020)
11.10.4 DURECT Corporation Transdermal Drug Patches Products Offered
11.10.5 DURECT Corporation Recent Development
11.1 Noven
11.1.1 Noven Corporation Information
11.1.2 Noven Description, Business Overview and Total Revenue
11.1.3 Noven Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Noven Transdermal Drug Patches Products Offered
11.1.5 Noven Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Transdermal Drug Patches Market Estimates and Projections by Region
12.1.1 Global Transdermal Drug Patches Sales Forecast by Regions 2021-2026
12.1.2 Global Transdermal Drug Patches Revenue Forecast by Regions 2021-2026
12.2 North America Transdermal Drug Patches Market Size Forecast (2021-2026)
12.2.1 North America: Transdermal Drug Patches Sales Forecast (2021-2026)
12.2.2 North America: Transdermal Drug Patches Revenue Forecast (2021-2026)
12.2.3 North America: Transdermal Drug Patches Market Size Forecast by Country (2021-2026)
12.3 Europe Transdermal Drug Patches Market Size Forecast (2021-2026)
12.3.1 Europe: Transdermal Drug Patches Sales Forecast (2021-2026)
12.3.2 Europe: Transdermal Drug Patches Revenue Forecast (2021-2026)
12.3.3 Europe: Transdermal Drug Patches Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Transdermal Drug Patches Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Transdermal Drug Patches Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Transdermal Drug Patches Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Transdermal Drug Patches Market Size Forecast by Region (2021-2026)
12.5 Latin America Transdermal Drug Patches Market Size Forecast (2021-2026)
12.5.1 Latin America: Transdermal Drug Patches Sales Forecast (2021-2026)
12.5.2 Latin America: Transdermal Drug Patches Revenue Forecast (2021-2026)
12.5.3 Latin America: Transdermal Drug Patches Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Transdermal Drug Patches Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Transdermal Drug Patches Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Transdermal Drug Patches Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Transdermal Drug Patches Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Transdermal Drug Patches Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Transdermal Drug Patches Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of TablesTable 1. Transdermal Drug Patches Market Segments
Table 2. Ranking of Global Top Transdermal Drug Patches Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Transdermal Drug Patches Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Fentanyl Transdermal Patch
Table 5. Major Manufacturers of Nicotine Transdermal Patch
Table 6. Major Manufacturers of Buprenorphine Transdermal Patch
Table 7. Major Manufacturers of Clonidine Transdermal Patch
Table 8. Major Manufacturers of Oxybutynin Transdermal Patch
Table 9. Major Manufacturers of Others
Table 10. COVID-19 Impact Global Market: (Four Transdermal Drug Patches Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Transdermal Drug Patches Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Transdermal Drug Patches Players to Combat Covid-19 Impact
Table 15. Global Transdermal Drug Patches Market Size Growth Rate by Application 2020-2026 (K Units)
Table 16. Global Transdermal Drug Patches Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 17. Global Transdermal Drug Patches Sales by Regions 2015-2020 (K Units)
Table 18. Global Transdermal Drug Patches Sales Market Share by Regions (2015-2020)
Table 19. Global Transdermal Drug Patches Revenue by Regions 2015-2020 (US$ Million)
Table 20. Global Transdermal Drug Patches Sales by Manufacturers (2015-2020) (K Units)
Table 21. Global Transdermal Drug Patches Sales Share by Manufacturers (2015-2020)
Table 22. Global Transdermal Drug Patches Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 23. Global Transdermal Drug Patches by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Drug Patches as of 2019)
Table 24. Transdermal Drug Patches Revenue by Manufacturers (2015-2020) (US$ Million)
Table 25. Transdermal Drug Patches Revenue Share by Manufacturers (2015-2020)
Table 26. Key Manufacturers Transdermal Drug Patches Price (2015-2020) (USD/Unit)
Table 27. Transdermal Drug Patches Manufacturers Manufacturing Base Distribution and Headquarters
Table 28. Manufacturers Transdermal Drug Patches Product Type
Table 29. Date of International Manufacturers Enter into Transdermal Drug Patches Market
Table 30. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 31. Global Transdermal Drug Patches Sales by Type (2015-2020) (K Units)
Table 32. Global Transdermal Drug Patches Sales Share by Type (2015-2020)
Table 33. Global Transdermal Drug Patches Revenue by Type (2015-2020) (US$ Million)
Table 34. Global Transdermal Drug Patches Revenue Share by Type (2015-2020)
Table 35. Transdermal Drug Patches Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 36. Global Transdermal Drug Patches Sales by Application (2015-2020) (K Units)
Table 37. Global Transdermal Drug Patches Sales Share by Application (2015-2020)
Table 38. North America Transdermal Drug Patches Sales by Country (2015-2020) (K Units)
Table 39. North America Transdermal Drug Patches Sales Market Share by Country (2015-2020)
Table 40. North America Transdermal Drug Patches Revenue by Country (2015-2020) (US$ Million)
Table 41. North America Transdermal Drug Patches Revenue Market Share by Country (2015-2020)
Table 42. North America Transdermal Drug Patches Sales by Type (2015-2020) (K Units)
Table 43. North America Transdermal Drug Patches Sales Market Share by Type (2015-2020)
Table 44. North America Transdermal Drug Patches Sales by Application (2015-2020) (K Units)
Table 45. North America Transdermal Drug Patches Sales Market Share by Application (2015-2020)
Table 46. Europe Transdermal Drug Patches Sales by Country (2015-2020) (K Units)
Table 47. Europe Transdermal Drug Patches Sales Market Share by Country (2015-2020)
Table 48. Europe Transdermal Drug Patches Revenue by Country (2015-2020) (US$ Million)
Table 49. Europe Transdermal Drug Patches Revenue Market Share by Country (2015-2020)
Table 50. Europe Transdermal Drug Patches Sales by Type (2015-2020) (K Units)
Table 51. Europe Transdermal Drug Patches Sales Market Share by Type (2015-2020)
Table 52. Europe Transdermal Drug Patches Sales by Application (2015-2020) (K Units)
Table 53. Europe Transdermal Drug Patches Sales Market Share by Application (2015-2020)
Table 54. Asia Pacific Transdermal Drug Patches Sales by Region (2015-2020) (K Units)
Table 55. Asia Pacific Transdermal Drug Patches Sales Market Share by Region (2015-2020)
Table 56. Asia Pacific Transdermal Drug Patches Revenue by Region (2015-2020) (US$ Million)
Table 57. Asia Pacific Transdermal Drug Patches Revenue Market Share by Region (2015-2020)
Table 58. Asia Pacific Transdermal Drug Patches Sales by Type (2015-2020) (K Units)
Table 59. Asia Pacific Transdermal Drug Patches Sales Market Share by Type (2015-2020)
Table 60. Asia Pacific Transdermal Drug Patches Sales by Application (2015-2020) (K Units)
Table 61. Asia Pacific Transdermal Drug Patches Sales Market Share by Application (2015-2020)
Table 62. Latin America Transdermal Drug Patches Sales by Country (2015-2020) (K Units)
Table 63. Latin America Transdermal Drug Patches Sales Market Share by Country (2015-2020)
Table 64. Latin Americaa Transdermal Drug Patches Revenue by Country (2015-2020) (US$ Million)
Table 65. Latin America Transdermal Drug Patches Revenue Market Share by Country (2015-2020)
Table 66. Latin America Transdermal Drug Patches Sales by Type (2015-2020) (K Units)
Table 67. Latin America Transdermal Drug Patches Sales Market Share by Type (2015-2020)
Table 68. Latin America Transdermal Drug Patches Sales by Application (2015-2020) (K Units)
Table 69. Latin America Transdermal Drug Patches Sales Market Share by Application (2015-2020)
Table 70. Middle East and Africa Transdermal Drug Patches Sales by Country (2015-2020) (K Units)
Table 71. Middle East and Africa Transdermal Drug Patches Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Transdermal Drug Patches Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Transdermal Drug Patches Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa Transdermal Drug Patches Sales by Type (2015-2020) (K Units)
Table 75. Middle East and Africa Transdermal Drug Patches Sales Market Share by Type (2015-2020)
Table 76. Middle East and Africa Transdermal Drug Patches Sales by Application (2015-2020) (K Units)
Table 77. Middle East and Africa Transdermal Drug Patches Sales Market Share by Application (2015-2020)
Table 78. Noven Corporation Information
Table 79. Noven Description and Major Businesses
Table 80. Noven Transdermal Drug Patches Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Noven Product
Table 82. Noven Recent Development
Table 83. Mylan Corporation Information
Table 84. Mylan Description and Major Businesses
Table 85. Mylan Transdermal Drug Patches Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Mylan Product
Table 87. Mylan Recent Development
Table 88. Novartis Corporation Information
Table 89. Novartis Description and Major Businesses
Table 90. Novartis Transdermal Drug Patches Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Novartis Product
Table 92. Novartis Recent Development
Table 93. Johnson & Johnson Corporation Information
Table 94. Johnson & Johnson Description and Major Businesses
Table 95. Johnson & Johnson Transdermal Drug Patches Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Johnson & Johnson Product
Table 97. Johnson & Johnson Recent Development
Table 98. Agile Therapeutics Corporation Information
Table 99. Agile Therapeutics Description and Major Businesses
Table 100. Agile Therapeutics Transdermal Drug Patches Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Agile Therapeutics Product
Table 102. Agile Therapeutics Recent Development
Table 103. Teikoku Pharma USA Corporation Information
Table 104. Teikoku Pharma USA Description and Major Businesses
Table 105. Teikoku Pharma USA Transdermal Drug Patches Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Teikoku Pharma USA Product
Table 107. Teikoku Pharma USA Recent Development
Table 108. Immune Pharmaceuticals Corporation Information
Table 109. Immune Pharmaceuticals Description and Major Businesses
Table 110. Immune Pharmaceuticals Transdermal Drug Patches Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Immune Pharmaceuticals Product
Table 112. Immune Pharmaceuticals Recent Development
Table 113. Hercon Pharmaceuticals Corporation Information
Table 114. Hercon Pharmaceuticals Description and Major Businesses
Table 115. Hercon Pharmaceuticals Transdermal Drug Patches Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Hercon Pharmaceuticals Product
Table 117. Hercon Pharmaceuticals Recent Development
Table 118. Pocono Corporation Information
Table 119. Pocono Description and Major Businesses
Table 120. Pocono Transdermal Drug Patches Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. Pocono Product
Table 122. Pocono Recent Development
Table 123. DURECT Corporation Corporation Information
Table 124. DURECT Corporation Description and Major Businesses
Table 125. DURECT Corporation Transdermal Drug Patches Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. DURECT Corporation Product
Table 127. DURECT Corporation Recent Development
Table 128. Xel Pharmaceuticals Corporation Information
Table 129. Xel Pharmaceuticals Description and Major Businesses
Table 130. Xel Pharmaceuticals Transdermal Drug Patches Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 131. Xel Pharmaceuticals Product
Table 132. Xel Pharmaceuticals Recent Development
Table 133. Global Transdermal Drug Patches Sales Forecast by Regions (2021-2026) (K Units)
Table 134. Global Transdermal Drug Patches Sales Market Share Forecast by Regions (2021-2026)
Table 135. Global Transdermal Drug Patches Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 136. Global Transdermal Drug Patches Revenue Market Share Forecast by Regions (2021-2026)
Table 137. North America: Transdermal Drug Patches Sales Forecast by Country (2021-2026) (K Units)
Table 138. North America: Transdermal Drug Patches Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Europe: Transdermal Drug Patches Sales Forecast by Country (2021-2026) (K Units)
Table 140. Europe: Transdermal Drug Patches Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Asia Pacific: Transdermal Drug Patches Sales Forecast by Region (2021-2026) (K Units)
Table 142. Asia Pacific: Transdermal Drug Patches Revenue Forecast by Region (2021-2026) (US$ Million)
Table 143. Latin America: Transdermal Drug Patches Sales Forecast by Country (2021-2026) (K Units)
Table 144. Latin America: Transdermal Drug Patches Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Middle East and Africa: Transdermal Drug Patches Sales Forecast by Country (2021-2026) (K Units)
Table 146. Middle East and Africa: Transdermal Drug Patches Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 148. Key Challenges
Table 149. Market Risks
Table 150. Main Points Interviewed from Key Transdermal Drug Patches Players
Table 151. Transdermal Drug Patches Customers List
Table 152. Transdermal Drug Patches Distributors List
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of FiguresFigure 1. Transdermal Drug Patches Product Picture
Figure 2. Global Transdermal Drug Patches Sales Market Share by Type in 2020 & 2026
Figure 3. Fentanyl Transdermal Patch Product Picture
Figure 4. Nicotine Transdermal Patch Product Picture
Figure 5. Buprenorphine Transdermal Patch Product Picture
Figure 6. Clonidine Transdermal Patch Product Picture
Figure 7. Oxybutynin Transdermal Patch Product Picture
Figure 8. Others Product Picture
Figure 9. Global Transdermal Drug Patches Sales Market Share by Application in 2020 & 2026
Figure 10. Used for Hypertension
Figure 11. Used for Contraception
Figure 12. Used for Analgesia
Figure 13. Used for Smoking Cessation
Figure 14. Used for Angina
Figure 15. Used for Hormone Replacement
Figure 16. Transdermal Drug Patches Report Years Considered
Figure 17. Global Transdermal Drug Patches Market Size 2015-2026 (US$ Million)
Figure 18. Global Transdermal Drug Patches Sales 2015-2026 (K Units)
Figure 19. Global Transdermal Drug Patches Market Size Market Share by Region: 2020 Versus 2026
Figure 20. Global Transdermal Drug Patches Sales Market Share by Region (2015-2020)
Figure 21. Global Transdermal Drug Patches Sales Market Share by Region in 2019
Figure 22. Global Transdermal Drug Patches Revenue Market Share by Region (2015-2020)
Figure 23. Global Transdermal Drug Patches Revenue Market Share by Region in 2019
Figure 24. Global Transdermal Drug Patches Sales Share by Manufacturer in 2019
Figure 25. The Top 10 and 5 Players Market Share by Transdermal Drug Patches Revenue in 2019
Figure 26. Transdermal Drug Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Transdermal Drug Patches Sales Market Share by Type (2015-2020)
Figure 28. Global Transdermal Drug Patches Sales Market Share by Type in 2019
Figure 29. Global Transdermal Drug Patches Revenue Market Share by Type (2015-2020)
Figure 30. Global Transdermal Drug Patches Revenue Market Share by Type in 2019
Figure 31. Global Transdermal Drug Patches Market Share by Price Range (2015-2020)
Figure 32. Global Transdermal Drug Patches Sales Market Share by Application (2015-2020)
Figure 33. Global Transdermal Drug Patches Sales Market Share by Application in 2019
Figure 34. Global Transdermal Drug Patches Revenue Market Share by Application (2015-2020)
Figure 35. Global Transdermal Drug Patches Revenue Market Share by Application in 2019
Figure 36. North America Transdermal Drug Patches Sales Growth Rate 2015-2020 (K Units)
Figure 37. North America Transdermal Drug Patches Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America Transdermal Drug Patches Sales Market Share by Country in 2019
Figure 39. North America Transdermal Drug Patches Revenue Market Share by Country in 2019
Figure 40. U.S. Transdermal Drug Patches Sales Growth Rate (2015-2020) (K Units)
Figure 41. U.S. Transdermal Drug Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada Transdermal Drug Patches Sales Growth Rate (2015-2020) (K Units)
Figure 43. Canada Transdermal Drug Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. North America Transdermal Drug Patches Market Share by Type in 2019
Figure 45. North America Transdermal Drug Patches Market Share by Application in 2019
Figure 46. Europe Transdermal Drug Patches Sales Growth Rate 2015-2020 (K Units)
Figure 47. Europe Transdermal Drug Patches Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Transdermal Drug Patches Sales Market Share by Country in 2019
Figure 49. Europe Transdermal Drug Patches Revenue Market Share by Country in 2019
Figure 50. Germany Transdermal Drug Patches Sales Growth Rate (2015-2020) (K Units)
Figure 51. Germany Transdermal Drug Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Transdermal Drug Patches Sales Growth Rate (2015-2020) (K Units)
Figure 53. France Transdermal Drug Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Transdermal Drug Patches Sales Growth Rate (2015-2020) (K Units)
Figure 55. U.K. Transdermal Drug Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Transdermal Drug Patches Sales Growth Rate (2015-2020) (K Units)
Figure 57. Italy Transdermal Drug Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Transdermal Drug Patches Sales Growth Rate (2015-2020) (K Units)
Figure 59. Russia Transdermal Drug Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Europe Transdermal Drug Patches Market Share by Type in 2019
Figure 61. Europe Transdermal Drug Patches Market Share by Application in 2019
Figure 62. Asia Pacific Transdermal Drug Patches Sales Growth Rate 2015-2020 (K Units)
Figure 63. Asia Pacific Transdermal Drug Patches Revenue Growth Rate 2015-2020 (US$ Million)
Figure 64. Asia Pacific Transdermal Drug Patches Sales Market Share by Region in 2019
Figure 65. Asia Pacific Transdermal Drug Patches Revenue Market Share by Region in 2019
Figure 66. China Transdermal Drug Patches Sales Growth Rate (2015-2020) (K Units)
Figure 67. China Transdermal Drug Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Japan Transdermal Drug Patches Sales Growth Rate (2015-2020) (K Units)
Figure 69. Japan Transdermal Drug Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. South Korea Transdermal Drug Patches Sales Growth Rate (2015-2020) (K Units)
Figure 71. South Korea Transdermal Drug Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. India Transdermal Drug Patches Sales Growth Rate (2015-2020) (K Units)
Figure 73. India Transdermal Drug Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Australia Transdermal Drug Patches Sales Growth Rate (2015-2020) (K Units)
Figure 75. Australia Transdermal Drug Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Taiwan Transdermal Drug Patches Sales Growth Rate (2015-2020) (K Units)
Figure 77. Taiwan Transdermal Drug Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Indonesia Transdermal Drug Patches Sales Growth Rate (2015-2020) (K Units)
Figure 79. Indonesia Transdermal Drug Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Thailand Transdermal Drug Patches Sales Growth Rate (2015-2020) (K Units)
Figure 81. Thailand Transdermal Drug Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Malaysia Transdermal Drug Patches Sales Growth Rate (2015-2020) (K Units)
Figure 83. Malaysia Transdermal Drug Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Philippines Transdermal Drug Patches Sales Growth Rate (2015-2020) (K Units)
Figure 85. Philippines Transdermal Drug Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Vietnam Transdermal Drug Patches Sales Growth Rate (2015-2020) (K Units)
Figure 87. Vietnam Transdermal Drug Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Asia Pacific Transdermal Drug Patches Market Share by Type in 2019
Figure 89. Asia Pacific Transdermal Drug Patches Market Share by Application in 2019
Figure 90. Latin America Transdermal Drug Patches Sales Growth Rate 2015-2020 (K Units)
Figure 91. Latin America Transdermal Drug Patches Revenue Growth Rate 2015-2020 (US$ Million)
Figure 92. Latin America Transdermal Drug Patches Sales Market Share by Country in 2019
Figure 93. Latin America Transdermal Drug Patches Revenue Market Share by Country in 2019
Figure 94. Mexico Transdermal Drug Patches Sales Growth Rate (2015-2020) (K Units)
Figure 95. Mexico Transdermal Drug Patches Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Brazil Transdermal Drug Patches Sales Growth Rate (2015-2020) (K Units)
Figure 97. Brazil Transdermal Drug Patches Revenue